Mikastar 500 Injection
Marketer
Mankind Pharma Ltd
Salt Composition
Amikacin (500mg)
Overview Mikastar 500 Injection
Ceftazidime 500mg Injection combats various bacterial infections, encompassing urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections. Prophylactic use in hospitalized patients is also indicated. Its mechanism involves bacterial growth inhibition. Administered intravenously (IV drip) or intramuscularly by a healthcare professional only, it requires regular, evenly spaced doses as prescribed. Complete the entire course, even with symptom improvement; premature cessation risks relapse or infection exacerbation. Common adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant medical consultation. High doses may exceptionally cause vertigo, nephrotoxicity, and ototoxicity. Adhere strictly to your doctor's instructions, including potential monitoring via kidney function, hearing, and urine tests. Pregnancy contraindicates its use; disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Uses of Mikastar 500 Injection
Infections caused by bacteria
Major Benefits of Mikastar 500 Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
Common Side effects of Mikastar 500 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikastar 500 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mikastar 500 Injection works:
Mikastar 500 Injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Mikastar 500 Injection presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikastar 500 Injection during pregnancy is contraindicated due to confirmed risks to fetal development. Exceptions may exist in critical circumstances where the physician deems the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Mikastar 500 Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, presenting no known danger to the infant.
DrivingUNSAFE
Administering Mikastar 500 Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is discouraged if these effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, administering Mikastar 500 Injection requires careful consideration. Dosage modification of Mikastar 500 Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Mikastar 500 Injection appears safe for use in individuals with hepatic impairment. Available evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Mikastar 500 Injection :
Should you forget a scheduled injection of Mikastar 500, seek medical advice.
Facts to Know About Mikastar 500 Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
| Behavior Class | Aminoglycoside antibiotics |



